Xeris Biopharma Holdings, Inc. (11)
Browse by Contract Category
Contracts
-
Second Amendment to API Supply Agreement, dated as of May 2, 2022, by and between
(Filed With SEC on August 10, 2022)
-
Form of Warrant to purchase common stock by and between the Registrant and Hayfin Services LLP
(Filed With SEC on May 11, 2022)
-
Open Market Sale Agreement
(Filed With SEC on May 11, 2022)
-
Amended and Restated Employment Agreement by and among the Registrant, Xeris Pharmaceuticals, Inc. and Beth Hecht dated as of October 5, 2021
(Filed With SEC on May 11, 2022)
-
Description of Registrant's Securities
(Filed With SEC on March 11, 2022)
-
Form of Warrant
(Filed With SEC on January 3, 2022)
-
Form of Securities Purchase Agreement between the Company and Armistice Capital Master Fund Ltd. dated as of January 2, 2022
(Filed With SEC on January 3, 2022)
-
Form of Registration Rights Agreement between the Company and Armistice Capital Master Fund Ltd. dated as of January 2, 2022
(Filed With SEC on January 3, 2022)
-
Amended and Restated Employment Agreement by and among the Registrant, Xeris Pharmaceuticals, Inc. and Paul Edick, dated as of October 5, 2021
(Filed With SEC on October 5, 2021)
-
Amended and Restated Employment Agreement by and among the Registrant, Xeris Pharmaceuticals, Inc. and John Shannon, dated as of October 5, 2021
(Filed With SEC on October 5, 2021)
-
Amended and Restated Employment Agreement by and among the Registrant, Xeris Pharmaceuticals, Inc. and Steven Pieper, dated as of October 5, 2021
(Filed With SEC on October 5, 2021)